Literature DB >> 11850787

Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis.

Jennifer A Hackett1, Carol W Greider.   

Abstract

Telomere shortening and telomerase activation both occur in human tumors. Telomere shortening has been proposed to have two conflicting roles in tumorigenesis: tumor suppression and initiation of chromosomal instability. Similarly, while telomerase activation is suggested to be necessary for tumor growth, telomerase may help to stabilize genomic instability. Here we review what is known about these conflicting roles and propose a framework to understand the role of telomerase in cancer progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850787     DOI: 10.1038/sj.onc.1205061

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  87 in total

1.  Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.

Authors:  Enrica Rampazzo; Laura Bonaldi; Livio Trentin; Carlo Visco; Sonia Keppel; Silvia Giunco; Federica Frezzato; Monica Facco; Elisabetta Novella; Ilaria Giaretta; Paola Del Bianco; Gianpietro Semenzato; Anita De Rossi
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

2.  Signaling through estrogen receptors modulates telomerase activity in human prostate cancer.

Authors:  Simona Nanni; Michela Narducci; Linda Della Pietra; Fabiola Moretti; Annalisa Grasselli; Piero De Carli; Ada Sacchi; Alfredo Pontecorvi; Antonella Farsetti
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

3.  Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  End resection initiates genomic instability in the absence of telomerase.

Authors:  Jennifer A Hackett; Carol W Greider
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

Review 5.  Telomere dynamics: the means to an end.

Authors:  M Matulić; M Sopta; I Rubelj
Journal:  Cell Prolif       Date:  2007-08       Impact factor: 6.831

6.  Effects of allicin on both telomerase activity and apoptosis in gastric cancer SGC-7901 cells.

Authors:  Li Sun; Xu Wang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  No attenuation of the ATM-dependent DNA damage response in murine telomerase-deficient cells.

Authors:  Natalie Erdmann; Lea A Harrington
Journal:  DNA Repair (Amst)       Date:  2008-12-25

Review 8.  Telomere diseases.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

9.  Telomere Length is a Susceptibility Marker for Tasmanian Devil Facial Tumor Disease.

Authors:  Lane E Smith; Menna E Jones; Rodrigo Hamede; Rosana Risques; Austin H Patton; Patrick A Carter; Andrew Storfer
Journal:  Ecohealth       Date:  2020-10-30       Impact factor: 3.184

10.  A prospective study of telomere length and the risk of skin cancer.

Authors:  Jiali Han; Abrar A Qureshi; Jennifer Prescott; Qun Guo; Li Ye; David J Hunter; Immaculata De Vivo
Journal:  J Invest Dermatol       Date:  2008-07-31       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.